GSK Can't Shake Calif. County's Avandia False Ad Claims
A Pennsylvania federal judge on Tuesday denied GlaxoSmithKline PLC's bid to partially dismiss false advertising claims brought by Santa Clara County, Calif., over GSK's diabetes medication Avandia, rejecting its argument that...To view the full article, register now.
Already a subscriber? Click here to view full article